(19)
(11) EP 1 105 489 A1

(12)

(43) Date of publication:
13.06.2001 Bulletin 2001/24

(21) Application number: 99939279.8

(22) Date of filing: 19.08.1999
(51) International Patent Classification (IPC)7C12N 15/31, C07K 14/295, A61K 48/00, A61K 31/70
(86) International application number:
PCT/CA9900/765
(87) International publication number:
WO 0011/180 (02.03.2000 Gazette 2000/09)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 20.08.1998 US 97198 P

(71) Applicant: Aventis Pasteur Limited
Toronto,Ontario M2R 3T4 (CA)

(72) Inventors:
  • MURDIN, Andrew, D.
    Newmarket, Ontario L3X 1V2 (CA)
  • DUNN, Pamela L.
    Mississauga, Ontario L5A 4B8 (CA)
  • OOMEN, Raymond, P.
    Schomberg, Ontario L0C 1T0 (CA)

(74) Representative: Bizley, Richard Edward et al
Hepworth, Lawrence, Bryer & BizleyMerlin HouseFalconry CourtBaker's Lane
EppingEssex CM16 5DQ
EppingEssex CM16 5DQ (GB)

   


(54) NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF CHLAMYDIA